Q-Line Biotech IPO Analysis: Reagent Maker Seizes Rs 214 Crore
Q-Line Biotech is raising Rs 214.48 crore via a book-building IPO on NSE SME Emerge, pricing its shares between Rs 326 and Rs 343.
Live Grey Market Premium
Today's IPO GMP, subscription figures, and estimated listing gains.
| Company | Price band | GMP | Est. listing | Status |
|---|---|---|---|---|
|
Black Opal Sme |
₹0–₹0 | ₹0 (0.0%) | ₹0 | Listed |
|
Pind Hospitality Sme |
₹0–₹0 | ₹0 (0.0%) | ₹0 | Listed |
|
Q-Line Biotech Sme |
₹0–₹0 | ₹0 (0.0%) | ₹0 | Listed |
GMP figures reflect unofficial grey-market trading and can change quickly — not a guaranteed listing price.
Latest analysis
Visit the blog
Q-Line Biotech IPO: Diagnostic Reagent Maker Hits Market with Rs 214 Crore Issue
Q-Line Biotech is raising Rs 214.48 crore through an SME IPO on NSE Emerge, pricing its…
Q-Line Biotech IPO: Diagnostic Reagent Maker Eyes Rs 214 Crore
Q-Line Biotech Ltd is hitting the market with a Rs 214.48 crore book-building IPO on the…
Q-Line Biotech IPO: Diagnostic Reagent Maker Hits the Market with a Rs 214 Crore Issue
Q-Line Biotech is raising Rs 214.48 crore via an SME IPO on the NSE Emerge platform,…
Understanding the numbers
What is GMP?
The price IPO shares trade at in the unofficial grey market before listing — the premium over the issue price reflects unofficial demand, not a guaranteed price.
Why subscription matters more
QIB (institutional) subscription is the more reliable signal — institutions do deep diligence before bidding. High GMP with weak QIB demand is worth a second look.
How to read this table
Est. listing = price band top + current GMP. It's an estimate, not a forecast — GMP can and does swing right up to listing day.